Midwives may independently prescribe, order and administer this drug.
(HBIg, HepaGam B®, HyperHEP B® S/D) is a fractionated human blood product that provides immediate, short-term protection against hepatitis B infection.
Indications and Clinical Use:
HBIg should be given immediately after birth to any infant born to either an HBsAg positive woman or woman at high risk for hepatitis B infection (i.e. intravenous drug user or sex trade worker) whose infection status in unknown or negative.
Dosage and Administration:
Infant: 0.5 mL IM immediately after birth, along with first dose of hepatitis B vaccine series